{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:30:08Z","timestamp":1772753408129,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["LH2022H039"],"award-info":[{"award-number":["LH2022H039"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Heilongjiang Provincial Foreign Expert","award":["G2023013"],"award-info":[{"award-number":["G2023013"]}]},{"name":"State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences","award":["SKLN-2022A003"],"award-info":[{"award-number":["SKLN-2022A003"]}]},{"name":"State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences","award":["SKLN-201801"],"award-info":[{"award-number":["SKLN-201801"]}]},{"name":"Key Program of National Natural Science Foundation of China","award":["32030045"],"award-info":[{"award-number":["32030045"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ischemic stroke (IS) is a significant and potentially life-threatening disease with limited treatment options, often resulting in severe disability. Bone marrow stromal cells (BMSCs) transplantation has exhibited promising neuroprotection following cerebral ischemia-reperfusion injury (CIRI). However, the effectiveness is hindered by their low homing rate when administered through the vein. In this study, we aimed to enhance the homing ability of BMSCs through lentivirus transfection to express fucosyltransferase 7. This glycosylation engineered CD44 on BMSCs to express hematopoietic cell E-selectin\/L-selectin ligand (HCELL), which is the most potent E-selectin ligand. Following enforced HCELL expression, the transplantation of BMSCs was then evaluated in a middle cerebral artery occlusion model. Results showed that HCELL+BMSCs significantly ameliorated neurological deficits and reduced the volume of cerebral infarction. Furthermore, the transplantation led to a decrease in apoptosis by upregulating BCL-2 and downregulating BAX, also reduced the mRNA levels of inflammatory factors, such as interleukin-1\u03b2 (IL-1\u03b2), IL-2, IL-6, and tumor necrosis factor-alpha (TNF-\u03b1) in the ischemic brain tissue. Notably, enforced HCELL expression facilitated the migration of BMSCs toward cerebral ischemic lesions and their subsequent transendothelial migration through the upregulation of PTGS-2, increased production of PGE2 and activation of VLA-4. In summary, our study demonstrates that transplantation of HCELL+BMSCs effectively alleviates CIRI, and that enforced HCELL expression enhances the homing of BMSCs to cerebral ischemic lesions and their transendothelial migration via PTGS-2\/PGE2\/VLA-4. These findings indicate that enforced expression of HCELL on BMSCs could serve as a promising therapeutic strategy for the treatment of ischemic stroke.<\/jats:p>","DOI":"10.1093\/stmcls\/sxae062","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:44:54Z","timestamp":1728038694000},"page":"1070-1084","source":"Crossref","is-referenced-by-count":6,"title":["Enforced hematopoietic cell E-selectin\/L-selectin ligand expression enhances bone marrow stromal cells homing and amelioration of cerebral ischemia-reperfusion injury via induction of prostaglandin E2"],"prefix":"10.1093","volume":"42","author":[{"given":"Lian","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yewei","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Heilongjiang Provincial Hospital , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changda","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-0114","authenticated-orcid":false,"given":"Yujun","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of Harbin Medical University , Harbin 150001 ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"2024121022253187100_CIT0001","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2024121022253187100_CIT0002","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/svn-2020-000457","article-title":"China stroke statistics 2019: a report from the national center for healthcare quality management in neurological diseases, China National clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations","volume":"5","author":"Wang","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"2024121022253187100_CIT0003","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2024121022253187100_CIT0004","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American stroke association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2024121022253187100_CIT0005","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.121.319948","article-title":"Advances in acute ischemic stroke therapy","volume":"130","author":"Xiong","year":"2022","journal-title":"Circ Res"},{"key":"2024121022253187100_CIT0006","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/biomedicines11010002","article-title":"Pediatric stroke: a review of common etiologies and management strategies","volume":"11","author":"Rawanduzy","year":"2022","journal-title":"Biomedicines"},{"key":"2024121022253187100_CIT0007","doi-asserted-by":"publisher","first-page":"5173732","DOI":"10.1155\/2017\/5173732","article-title":"Mesenchymal stem and progenitor cells in regeneration: tissue specificity and regenerative potential","volume":"2017","author":"Rohban","year":"2017","journal-title":"Stem Cells Int."},{"issue":"1","key":"2024121022253187100_CIT0008","first-page":"3102","article-title":"Stem cell implants: emerging innovation for stroke recovery","volume":"3","author":"Colliander","year":"2023","journal-title":"J Neuro Oncol Res."},{"key":"2024121022253187100_CIT0009","doi-asserted-by":"publisher","first-page":"9923566","DOI":"10.1155\/2021\/9923566","article-title":"Progress in mesenchymal stem cell therapy for ischemic stroke","volume":"2021","author":"Guo","year":"2021","journal-title":"Stem Cells Int."},{"key":"2024121022253187100_CIT0010","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1007\/s00415-020-10138-5","article-title":"Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential","volume":"268","author":"Li","year":"2021","journal-title":"J Neurol"},{"key":"2024121022253187100_CIT0011","doi-asserted-by":"publisher","first-page":"217","DOI":"10.15283\/ijsc21136","article-title":"Effects and mechanisms of bone marrow mesenchymal stem cell transplantation for treatment of ischemic stroke in hypertensive rats","volume":"15","author":"Liu","year":"2022","journal-title":"Int J Stem Cells"},{"key":"2024121022253187100_CIT0012","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/dmcn.15325","article-title":"Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: an open-label, randomized trial","volume":"64","author":"Sun","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"2024121022253187100_CIT0013","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41390-022-02208-3","article-title":"Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies","volume":"95","author":"Lehnerer","year":"2024","journal-title":"Pediatr Res"},{"key":"2024121022253187100_CIT0014","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12974-019-1400-0","article-title":"The spleen may be an important target of stem cell therapy for stroke","volume":"16","author":"Wang","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2024121022253187100_CIT0015","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-019-1571-8","article-title":"Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles","volume":"16","author":"Dabrowska","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2024121022253187100_CIT0016","doi-asserted-by":"publisher","first-page":"113700","DOI":"10.1016\/j.expneurol.2021.113700","article-title":"Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1\/M2 phenotypes","volume":"341","author":"Liu","year":"2021","journal-title":"Exp Neurol"},{"key":"2024121022253187100_CIT0017","doi-asserted-by":"publisher","first-page":"e12024","DOI":"10.1002\/jev2.12024","article-title":"Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25","volume":"10","author":"Kuang","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"2024121022253187100_CIT0018","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/biom12070883","article-title":"Exosomes derived from bone marrow mesenchymal stem cells promote angiogenesis in ischemic stroke mice via upregulation of MiR-21-5p","volume":"12","author":"Hu","year":"2022","journal-title":"Biomolecules"},{"key":"2024121022253187100_CIT0019","doi-asserted-by":"publisher","first-page":"111709","DOI":"10.1016\/j.biopha.2021.111709","article-title":"Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model","volume":"140","author":"Asgari Taei","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2024121022253187100_CIT0020","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol Ther"},{"key":"2024121022253187100_CIT0021","doi-asserted-by":"publisher","first-page":"646927","DOI":"10.3389\/fcell.2021.646927","article-title":"Potential mechanisms and perspectives in ischemic stroke treatment using stem cell therapies","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024121022253187100_CIT0022","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/adfm.201402930","article-title":"MRI\/SPECT\/Fluorescent tri-modal probe for evaluating the homing and therapeutic efficacy of transplanted mesenchymal stem cells in a rat ischemic stroke model","volume":"25","author":"Tang","year":"2015","journal-title":"Adv Funct Mater"},{"key":"2024121022253187100_CIT0023","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/STROKEAHA.115.009854","article-title":"Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke","volume":"46","author":"Acosta","year":"2015","journal-title":"Stroke"},{"key":"2024121022253187100_CIT0024","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal stromal cell homing: mechanisms and strategies for improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"key":"2024121022253187100_CIT0025","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.2466335","article-title":"Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins","volume":"243","author":"Bevilacqua","year":"1989","journal-title":"Science"},{"key":"2024121022253187100_CIT0026","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/blood.V84.10.3299.3299","article-title":"Detection of an L-selectin ligand on a hematopoietic progenitor cell line","volume":"84","author":"Oxley","year":"1994","journal-title":"Blood"},{"key":"2024121022253187100_CIT0027","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood.V89.8.2773","article-title":"A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity","volume":"89","author":"Sackstein","year":"1997","journal-title":"Blood"},{"key":"2024121022253187100_CIT0028","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood.V96.8.2765","article-title":"A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan\u2013dependent binding activity","volume":"96","author":"Sackstein","year":"2000","journal-title":"Blood"},{"key":"2024121022253187100_CIT0029","doi-asserted-by":"publisher","first-page":"13841","DOI":"10.1073\/pnas.250484797","article-title":"A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells","volume":"97","author":"Dimitroff","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024121022253187100_CIT0030","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1083\/jcb.153.6.1277","article-title":"CD44 is a major E-selectin ligand on human hematopoietic progenitor cells","volume":"153","author":"Dimitroff","year":"2001","journal-title":"J Cell Biol"},{"key":"2024121022253187100_CIT0031","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.semcdb.2019.03.003","article-title":"Mesenchymal stem cell therapies in brain disease","volume":"95","author":"Sherman","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"2024121022253187100_CIT0032","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nat Med"},{"key":"2024121022253187100_CIT0033","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1073\/pnas.1018064108","article-title":"Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells","volume":"108","author":"Thankamony","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024121022253187100_CIT0034","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/stem.1948","article-title":"HCELL expression on murine MSC licenses Pancreatotropism and confers durable reversal of autoimmune diabetes in NOD Mice","volume":"33","author":"Abdi","year":"2015","journal-title":"Stem Cells"},{"key":"2024121022253187100_CIT0035","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexcr.2016.11.010","article-title":"CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury","volume":"350","author":"Chou","year":"2017","journal-title":"Exp Cell Res"},{"key":"2024121022253187100_CIT0036","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neuroscience.2019.06.041","article-title":"Over-expression of TRPC6 via CRISPR based synergistic activation mediator in BMSCs ameliorates brain injury in a rat model of cerebral ischemia\/reperfusion","volume":"415","author":"Li","year":"2019","journal-title":"Neuroscience"},{"key":"2024121022253187100_CIT0037","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/stem.2549","article-title":"A glycovariant of human CD44 is characteristically expressed on human mesenchymal stem cells","volume":"35","author":"Pachon-Pena","year":"2017","journal-title":"Stem Cells"},{"key":"2024121022253187100_CIT0038","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.str.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"2024121022253187100_CIT0039","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.str.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"2024121022253187100_CIT0040","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1172\/JCI43165","article-title":"Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats","volume":"120","author":"Du","year":"2010","journal-title":"J Clin Invest"},{"key":"2024121022253187100_CIT0041","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"key":"2024121022253187100_CIT0042","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.actbio.2022.10.022","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models","volume":"154","author":"Qiu","year":"2022","journal-title":"Acta Biomater"},{"key":"2024121022253187100_CIT0043","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/j.febslet.2011.07.039","article-title":"CD44 and HCELL: preventing hematogenous metastasis at step 1","volume":"585","author":"Jacobs","year":"2011","journal-title":"FEBS Lett"},{"key":"2024121022253187100_CIT0044","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOH.0b013e3283476140","article-title":"The biology of CD44 and HCELL in hematopoiesis: the \u201cstep 2-bypass pathway\u201d and other emerging perspectives","volume":"18","author":"Sackstein","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"2024121022253187100_CIT0045","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/stem.2435","article-title":"Glycoengineering of E-selectin ligands by intracellular versus extracellular fucosylation differentially affects osteotropism of human mesenchymal stem cells","volume":"34","author":"Dykstra","year":"2016","journal-title":"Stem Cells"},{"key":"2024121022253187100_CIT0046","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/00004647-200209000-00004","article-title":"Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury","volume":"22","author":"Berti","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"2024121022253187100_CIT0047","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0006-8993(97)01343-7","article-title":"The expression of P- and E-selectins in three models of middle cerebral artery occlusion","volume":"785","author":"Zhang","year":"1998","journal-title":"Brain Res"},{"key":"2024121022253187100_CIT0048","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1349-7006.2005.00022.x","article-title":"Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin","volume":"96","author":"Yazawa","year":"2005","journal-title":"Cancer Sci"},{"key":"2024121022253187100_CIT0049","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.7150\/thno.25434","article-title":"Suspension state promotes metastasis of breast cancer cells by up-regulating cyclooxygenase-2","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"2024121022253187100_CIT0050","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.fertnstert.2010.01.070","article-title":"Suppression of migratory\/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors","volume":"94","author":"Chen","year":"2010","journal-title":"Fertil Steril"},{"key":"2024121022253187100_CIT0051","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jsps.2017.04.011","article-title":"Expression of CD44 standard form and variant isoforms in human bone marrow stromal cells","volume":"25","author":"Wang","year":"2017","journal-title":"Saudi Pharm J"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxae062\/60298300\/sxae062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/12\/1070\/60971763\/sxae062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/12\/1070\/60971763\/sxae062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:26:01Z","timestamp":1733869561000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/42\/12\/1070\/7810890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,10,4]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxae062","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,4]]}}}